Lazard Asset Management’s Agilon Health AGL Stock Holding History

Lazard Asset Management’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-30,040	Closed	-$238K	–	1942
2026 Q1	$238K	Buy	+30,040	New	+$486K	﹤0.01%	1580
2022 Q3	–	Sell	-275	Closed	-$150K	–	2287
2022 Q2	$150K	Buy	275 +165	+150%	+$83.5K	﹤0.01%	1359
2022 Q1	$69K	Buy	+110	New	+$56.7K	﹤0.01%	1567

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NPCM

North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Lazard Asset Management's AGL Position: Q2 2026 in Review

Lazard Asset Management sold out of Agilon Health (AGL) in Q2 2026, closing a stake of 30,040 shares — an estimated $238K sold.

Lazard Asset Management first reported a position in AGL in Q1 2022 and held it in 3 quarters. The position peaked at $238K in Q1 2026. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

Lazard Asset Management reported no remaining Agilon Health position as of Q2 2026 after selling out during the quarter.
Lazard Asset Management sold 30,040 Agilon Health shares in Q2 2026, an estimated $238K.
Lazard Asset Management first reported a position in Agilon Health in Q1 2022 and held it in 3 quarters.
Lazard Asset Management's Agilon Health position peaked at $238K in Q1 2026.
179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.